News

Dana Boucher found relief with LUTATHERA, a targeted radioactive therapy specifically for neuroendocrine tumors (NETs) found in the gut or pancreas.

Born with congenital heart disease, Christin Murphy, 41, was familiar with cardiology appointments, stress tests, and surgeries.

After years of life-threatening cardiac episodes and chest pain, Cindy Mager, 59, became the first Saint Luke's patient to undergo this innovative, life-saving procedure.

Survival rates for Black women are far worse after bystander CPR than for white men, according to a study published this month.

USA Today talked to Dr. Paul Chan about disparities found when analyzing the effectiveness of bystander CPR for cardiac arrest.

Saint Luke’s Mid America Heart Institute was the first in Kansas and Missouri, and one of only 27 US institutions, to participate in PULSED AF clinical trial.

TAVR in asymptomatic and minimally symptomatic patients is associated with a high survival rate, but relatively minor improvements, according to new research.

Dr. Mikhail Kosiborod presented on the benefits of a cardiometabolic center of excellence for patients with cardiometabolic diseases at the ADA conference in San Diego.

Dr. Sanjaya Gupta, electrophysiologist at Saint Luke's Mid America Heart Institute, talks with KCTV about risk factors and new treatment available at Saint Luke's Atrial Fibrillation Clinic.

Rehospitalization after aortic valve replacement (AVR) is associated with an increased risk of patient mortality, according to new research.